Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants
Stopped early
Conditions studied: HIV Infections, Pregnancy
In brief
The purpose of this study is to set up a blood bank for infants who have HIV-positive mothers. This blood may be used in the future to treat the child if he/she turns out to be HIV-positive. Blood from the umbilical cord contains a certain kind of cell called a stem cell. Stem cells eventually turn into one of the many types of blood cells. If HIV infection can be prevented in these stem cells, then, when these stem cells are injected back into the infant, the new cells that develop will also be protected from HIV. This study will provide the blood needed to test whether this type of gene therapy is safe and effective.
Key facts
- Study ID
- NCT00000917
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 200
- Starts
- 1997-09-01
- Last updated by the study team
- 2008-08-01
Who can join
Age: 0 and older, up to 1. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- You may be eligible for this study if you:
- Are HIV-positive.
You may not qualify if…
- Your child will not be eligible for this study if he/she:
- Is not expected to live more than 6 months.
- Weighs less than 3.3 pounds.
Where it is running
- UCSD Med Ctr / Pediatrics / Clinical Sciences — La Jolla, California, United States
- Long Beach Memorial (Pediatric) — Long Beach, California, United States
- Los Angeles County - USC Med Ctr — Los Angeles, California, United States
- Cedars Sinai / UCLA Med Ctr — Los Angeles, California, United States
- UCLA Med Ctr / Pediatric — Los Angeles, California, United States
- Harbor - UCLA Med Ctr / UCLA School of Medicine — Los Angeles, California, United States
- San Francisco Gen Hosp — San Francisco, California, United States
- UCSF / Moffitt Hosp - Pediatric — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.